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1. Introduction 
Neocarzinostatin (NCS) is an anti-tumor polypep- 
tide antibiotic, isolated from a culture filtrate of 
Streptomyces carzinostaticus [l] . It is an acidic 
single-chain polypeptide with a molecular weight of 
about 9000 [2] . Biochemical studies have shown 
that NCS specifically inhibits deoxyribonucleic acid 
synthesis in susceptible microorganisms [3,4] or in 
mammalian tumor cells [S] . Chemical investigations 
of the amino acid composition established the pres- 
ence of two tryptophan residues [7] and the absence 
of histidine and methionine residues [2]. All opti- 
cally active amino acids appear to be of the L config- 
uration since no significant oxygen uptake was ob- 
served manometrically when an acid hydrolysate 
of NCS was treated with D-amino acid oxidase [ 2, 81 
NCS contains four half-cystine residues forming two 
disulfide bridges [ 21. The occurrence of NH*-termi- 
nal alanine and of COOH-terminal asparagine has 
been reported earlier [2, 61. Investigations of amino- 
terminal and carboxy-terminal amino acid sequences 
are herein reported. 
2. Materials and methods 
Crude NCS was prepared by Kayaku Antibiotics 
* On leave of absence from Tohoku University School of 
Medicine, Sendai, Japan. 
North-Holland Pu blishing Company - Amsterdam 
Research Laboratory, Inc., Tokyo, and obtained 
through the courtesy of Dr. N.Ishida, Tohoku Univer- 
sity, Sendai, Japan. It was purified five-fold by re- 
peated chromatography on CM-cellulose, followed 
each time by Sephadex G-50 column chromatography 
as described previously [ 21 . For heat denaturation a 
1% solution of NCS in 1% NaHC03 was heated in a 
water bath at 80” for 20 min. Reduction and S-benzy- 
lation in liquid ammonia gave single-chain tetra S- 
benzyl NCS [9] . Phenylisothiocyanate (PITC, East- 
man Kodak, Rochester, N.Y., USA) was distilled in 
vacua. Constant boiling HCl was twice distilled. All 
other chemicals were of reagent grade and were used 
without further purification. Leucine aminopeptidase 
(LAPC, 100 units/mg, EC 3.4.1.1) and diisopropyl- 
phosphofluoridate-treated carboxypeptidase A 
(COADFP, 45.8 units/mg, EC 3.4.2.1) were obtained 
from Worthington Biochemical Corp., Freehold, N.J., 
USA. The carboxypeptidase was further purified by 
washing four times with distilled water [ lo] . 
2.1. NH,-terminal analysis 
The dansylation reaction [ 1 l] and the identifica- 
tion after acid hydrolysis of the dansyl amino acids 
on polyamide thin-layer sheets t were done according 
to the procedure of Woods and Wang [ 121. 
For the Edman degradation [ 13- 151 native NCS 
(1.5 pmoles) in pyridine-water (1: 1, v/v, 2-3 ml, ad- 
t We thank Dr. K.T.Wang of National Taiwan University, Taipei, 
Taiwan, for supplying us with polyamide thin-layer sheets. 
301 
Volume 9, number 5 FEBS LETTERS August 1970 
jsuted to pH 9.0-9.5 with 0.1 N NaOH) was treated 
with PITC (50 ~1, approximately 200-fold excess) 
for 2 hr at 40” under nitrogen in a closed test tube. 
After the removal of excess PITC by five washings 
with thiophene-free benzene (Merck and Co., Inc., 
Rahway, N.J., USA) the solution was brought to 
dryness in vacua. The phenylthiocarbamoyl-peptide 
was treated with trifluoroacetic acid for 15 min at 
40” under nitrogen. After removal of trifluoroacetic 
acid in uacuo the residue was dissolved in 0.1 N 
acetic acid and the solution was washed four times 
with ethyl acetate to remove the phenylthiohydantoin 
derivative. An aliquot of this solution was taken for 
dansylation. The remaining solution was subjected 
to further Edman degradation. 
mination and of the sequential Edman degradation 
methods was employed. Repeated experiments on 
native NCS gave unequivocal and reproducible results 
up to the fourth position, thus establishing the amino- 
terminal sequence as NH*-Ala-Ala-Pro-Thr-. This 
sequence confirms the earlier report [2] that alanine 
is the NH*-terminal amino acid of NCS. On treatment 
of native NCS with leucine aminopeptidase [ 191, only 
10% of the expected amount of alanine was obtained, 
possibly due to the proline residue in position 3. 
3.2. COOKterminal sequence 
2.2. COOH-terminal analysis 
Heat-denatured NCS or tetra?S-benzyl NCS (5.6 
mg, 0.6 pmole) was dissolved in 0.1 M NaHCO, 
(3 ml) and carboxypeptidase A (0.2 mg) was added. 
Digestions were done at 22”. Samples were taken at 
the intervals indicated in fig. 1 and reactions were 
stopped by addition of acetic acid (3-4 drops). The 
samples were thoroughly dried in uacuo and sub- 
jected to amino acid analysis [ 16, 171. 
Asparagine and serine gave one single peak on 
the recorder of the amino acid analyzer. To identify 
asparagine and to determine the individual values 
of each of the two amino acids, asparagine was con- 
verted into aspartic acid which appeared in a differ- 
ent position on amino acid analysis. The serine values 
were obtained by subtraction of the aspartic acid 
values from the original peak. For these purposes 
a separate carboxypeptidase digest was prepared. The 
enzyme and residual NCS were removed from the 
reaction mixture by precipitation with trichloroacetic 
acid (7.5% in water) followed by centrifugation. Re- 
peated washing of the supernatant with peroxide-free 
ether removed the trichloroacetic acid. The remaining 
amino acid mixture was then treated with 3.5 M HCl 
at 100” for 1.5 hr [ 181 and the liberated aspartic acid 
was determined by amino acid analysis. 
Chronological studies [lo] of the release of amino 
acids during carboxypeptidase A digestion were con- 
ducted. Because native NCS was digested too slowly 
to give useful results, both heat denatured and tetra- 
S-benzyl NCS were used. Both gave similar results; an 
example is shown in fig. 1. Asparagine and phenyl- 
alanine were released at almost identical rates and in 
almost the same quantities. During the first few min- 
utes, however, the asparagine release was slightly 
higher. These observations confirmed the previous de- 
termination [6] of asparagine as the C-terminal amino 
acid of NCS by a tritiation-racemization procedure 
[20], A total of six amino acids were released in the 
order: asparagine, phenylalanine, isoleucine, alanine, 
valine, and serine. After 6 hr incubation, the released 
amounts of each amino acid approached 90% of the 
theoretical yield. Neither larger amounts of any of 
these six amino acids nor any other amino acid were 
detected even after enzymatic treatment for 20 hr. 
The results (fig. 1) established the sequence Ser-Val- 
-Ala-lle-Phe-Asn-OH as the COOH-terminal hexapep- 
tide of NCS. 
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3. Results and discussion 
3.1. NH,-terminal sequence MINUTES 
A combination of the dansyl aminoterminal deter- Fig. 1. 
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